Introduction {#s1}
============

Network activity in the cerebral cortex is controlled by the interplay of two distinct cell classes: excitatory and inhibitory neurons. While excitatory neurons are long projecting and use glutamate as their main neurotransmitter, inhibitory neurons are mostly locally projecting cells (i.e., interneurons) that use gamma aminobutyric acid (GABA) to control the activity of excitatory cells ([@bib8]). In the mouse, cortical GABAergic interneurons are generated during embryonic development in transient neurogenic regions of the basal forebrain known as the medial and caudal ganglionic eminences (MGE and CGE, respectively) and preoptic area ([@bib23]; [@bib10]). They migrate dorsally following a route tangential to the brain surface to colonize the entire neocortex ([@bib11]; [@bib31]; [@bib59]). GABAergic interneurons are a diverse, highly heterogeneous cell population displaying varied morphological, electrophysiological, and molecular characteristics ([@bib32]; [@bib3]; [@bib26]). More recently, single-cell gene expression studies have further contributed to our understanding of the molecular diversity of this class of neurons ([@bib53]; [@bib65]). The specification and maturation of the different interneuron subtypes are regulated by the concerted action of genetic and activity-dependent factors ([@bib57]). Different combinations of transcription factors function in a sequential fashion to progressively refine the specification of individual interneuron subclasses. MGE-derived somatostatin (SST)--expressing interneurons constitute ∼30% of all cortical GABAergic interneurons and comprise a morphologically ([@bib40]), functionally ([@bib22]; [@bib62]), and molecularly ([@bib53], [@bib52]) diverse class that populates cortical layers II to VI. The development of this subtype is controlled by the sequential activity of the transcription factors Nkx2.1, Lhx6, and SATB1 ([@bib6]; [@bib13]; [@bib27]; [@bib44]; [@bib45]; [@bib9]; [@bib15]). While Nkx2.1 and Lhx6 contribute to specify precursors common to both SST and parvalbumin (PV) interneurons, SATB1 is a major determinant of the SST subtype ([@bib9]; [@bib13]). In agreement with its established role in ventral patterning, Sonic hedgehog signaling is required for the early patterning of the basal forebrain as well as Nkx2.1 expression ([@bib19]; [@bib60]). Aside from this early function, it is still not understood how transcriptional programs that specify the distinct types of cortical interneurons interact with extracellular cues present in the environment of MGE cells.

Activin receptor-like kinase 4 (ALK4) is a type I serine-threonine kinase receptor for a subset of TGFβ superfamily ligands that includes activins A and B, as well as members of the Growth Differentiation Factor (GDF) subfamily, including GDF-1, -3 and -5, among others ([@bib49] [@bib39] [@bib54]). Ligand binding to type II receptors ActrIIA or ActrIIB recruits ALK4 to the complex, resulting in ALK4 GlySer (GS)-domain phosphorylation and activation of the ALK4 kinase ([@bib5]; [@bib33]). Similar to other type I receptors, canonical signaling by ALK4 involves the recruitment and phosphorylation of Smad proteins 2 and 3, which then partner with Smad 4 and translocate to the cell nucleus, where they regulate gene expression in conjunction with cell type--specific transcription factors ([@bib49]; [@bib5]; [@bib33]). ALK4 is expressed in the extra-embryonic ectoderm and in the epiblast of early post-implantation embryos; by midgestation, its expression is nearly ubiquitous, including the central nervous system ([@bib20]; [@bib56]). A null mutation in mouse *Acvr1b*, the gene encoding ALK4, is embryonic lethal due to defects in primitive streak formation and gastrulation ([@bib20]), and no conditional approaches have yet been reported to address the function of this receptor in nervous system development or function. Despite the importance of the ALK4 signaling system in the development of many peripheral organs and tissues, there is a large gap of knowledge on its possible functions in the brain.

In this study, using different lines of conditional mutant mice, we show that ALK4 is indispensable for the development of cortical SST-expressing GABAergic interneurons. ALK4 signaling is required before the acquisition of the SST phenotype and contributes to the nuclear localization and function of SATB1, a critical transcriptional determinant of SST interneuron specification. A marked paucity of SST interneurons in layer IV resulted in abnormal activity of the inhibitory circuit in this cortical layer. These results define a previously unknown function of ALK4 in the basal forebrain, linking intracellular transcription factor cascades known to govern interneuron development to the extracellular environment of the developing brain.

Results {#s2}
=======

Loss of SST^+^ cortical interneurons after deletion of ALK4 in GABAergic cells of the MGE {#s3}
-----------------------------------------------------------------------------------------

To dissect cell-autonomous functions of ALK4 in specific tissues, we generated a conditional null allele of the mouse *Acvr1b* gene (*Alk4*^fl^) with loxP sites flanking exons 5 and 6, encoding essential regions of the ALK4 kinase domain ([Fig. S1 A](#figS1){ref-type="fig"}). Gene deletion in GABAergic neurons was achieved by crossing *Alk4*^fl/fl^ and *Gad67*^Cre^ mice. Earlier radioactive in situ hybridization studies had shown low but widespread expression of *Alk4* mRNA in the developing basal forebrain ([@bib56]). In our hands, conventional histological methods with standard riboprobes or commercially available antibodies did not give adequate results. However, using RNAscope in situ hybridization, a method of much greater sensitivity, we succeeded to detect *Alk4* mRNA expression in the mantle zone of the MGE in WT embryonic day (E) 12.5 mouse embryos ([Fig. 1](#fig1){ref-type="fig"}). The signal for *Alk4* mRNA overlapped with that of *Lhx6* mRNA ([Fig. 1](#fig1){ref-type="fig"}), a specific marker of MGE-derived, postmitotic GABAergic interneurons ([@bib27]; [@bib15]). *Alk4* mRNA levels in the ventricular and subventricular zones (VZ and SVZ, respectively), containing proliferating precursors labeled by PCNA staining, were very low ([Fig. 1](#fig1){ref-type="fig"}), indicating a predominantly postmitotic expression of *Alk4* mRNA in the mouse MGE. Importantly, the *Alk4* mRNA signal was significantly reduced in the MGE mantle zone of *Gad67*^Cre^:*Alk4*^fl/fl^ mutant embryos ([Fig. S2](#figS2){ref-type="fig"}). We also detected significant levels of mRNAs encoding various ALK4 ligands, including *InhbA* (for activin A), *InhbB* (for activin B), and *Gdf1*, in the subpallium of E12.5 and E14.5 *Alk4* mutant and control embryos ([Fig. S2, A--C](#figS2){ref-type="fig"}).

![***Alk4* mRNA expression in the mantle zone of the MGE.** RNAscope in situ hybridization analysis of *Alk4* mRNA expression (green) in the VZ and mantle zone (here labeled MZ) of the MGE in WT E12.5 mouse embryos. Upper row shows lower magnification images. Middle and lower rows show higher magnification images of VZ and MZ, respectively, of areas boxed in upper panel. In situ hybridization for *Lhx6* mRNA was used as marker for postmitotic interneurons of the MGE (purple). Immunohistochemistry for PCNA (red) was used to mark proliferating cells in the VZ. Counterstaining with DAPI is shown in blue. Note that the *Alk4* mRNA signal overlaps with the area labeled by *Lhx6* mRNA in the mantle zone, but not with that labeled by PCNA in the proliferative zone. Arrowheads point to blood vessels, which show unspecific signal in the green channel. Scale bars, 100 µm (upper row); 20 µm (middle and lower rows).](JCB_201905002_Fig1){#fig1}

![**Generation ofa conditional allele of the mouse Acvr1b gene encoding ALK4 (A) and analysis of Alk4 mRNA expression in the MGE of Alk4 mutant mice (B).** **(A)** CRE-mediated recombination deletes exons 5 and 6, encoding the ALK4 kinase domain, which is essential for signaling, and introduces an in-frame stop codon after exon 4. **(B)** RNAscope in situ hybridization analysis of Alk4 (green) and Lhx6 (purple) mRNA and PCNA protein (red) expression in mutant (Gad67Cre:Alk4fl/fl) E12.5 mouse embryos. Middle and lower rows show higher magnification images of VZ and MZ, respectively, of areas boxed in upper panel. Alk4 mRNA expression was abolished in areas positive for Lhx6 mRNA in these mutants (compare to WT shown in [Fig. 1](#fig1){ref-type="fig"}). Arrowheads point to blood vessels (showing unspecific signal in the green channel). Scale bars, 100 µm (upper row); 20 µm (middle and lower rows). KO, knock-out.](JCB_201905002_FigS1){#figS1}

![**Expression of mRNAs encoding ALK4 ligands in the embryonic basal forebrain (A--C) and assessment of recombination efficiency driven by *Gad67*^Cre^ in cortical GABAergic interneurons. (A--C)** Expression of *Inhba* (A), *Inhbb* (B), and *Gdf1* (C) mRNAs in basal forebrain of control (*Alk4*^fl/fl^, gray bars) and mutant (*Gad67*^Cre^:*Alk4*^fl/fl^, black bars) E12.5 and E14.5 mouse embryos. Results are presented as mean ± SEM. *n* = 8 (E12.5 *Alk4*^fl/fl^), 6 (E12.5 *Gad67*^Cre^:*Alk4*^fl/fl^), 6 (E14.5 *Alk4*^fl/fl^), and 8 (E14.5 *Gad67*^Cre^:*Alk4*^fl/fl^). \*, P \< 0.05 (ANOVA, Bonferroni post hoc test). **(D)** Representative confocal images of fluorescence immunohistochemical detection of GABAergic interneuron markers (green) as indicated and tdTomato (red) in the somatosensory cortex of P30 Gad67Cre:Rosa26tdTom mice. Arrowheads point to a selection of cells coexpressing tdTomato and the respective marker. Scale bars, 100 µm. **(E)** Quantification of tdTomato^+^ cells coexpressing the indicated markers relative to the total of tdTomato^+^ cells counted. Results are expressed as mean percentage ± SD. *n* = 3 mice, three nonconsecutive sections counted per mouse. InhbA, inhibin A.](JCB_201905002_FigS2){#figS2}

We used a *Rosa26*^tdTom^ reporter allele to assess recombination efficiency driven by *Gad67*^Cre^ among cortical GABAergic interneurons. We found that 80--90% of cells expressing SST, PV, Reelin (RELN), or vasoactive intestinal peptide (VIP) were positive for tdTomato in the cortex of postnatal day 30 (P30) *Gad67*^Cre^:*Rosa26*^tdTom^ mice ([Fig. S2, D and E](#figS2){ref-type="fig"}), indicating high levels of recombination. Loss of ALK4 in GABAergic cells (*Gad67*^Cre^:*Rosa26*^tdTom^:*Alk4*^fl/fl^ mice) resulted in 34.6 ± 4% reduction in tdTomato^+^ cells in the P30 somatosensory cortex compared with control mice (*Gad67*^Cre^:*Rosa26*^tdTom^:*Alk4*^+/+^), with cell losses in all layers, except layer I ([Fig. 2, A and B](#fig2){ref-type="fig"}). We assessed cell numbers among different classes of cortical interneurons, including nonoverlapping subpopulations of MGE-derived SST^+^ and PV^+^ neurons, VIP^+^ neurons derived from the CGE, and RELN^+^ neurons derived from both the MGE and CGE ([Fig. 2, C--G](#fig2){ref-type="fig"}). In these experiments, we compared mutant *Gad67*^Cre^:*Alk4*^fl/fl^ mice to three types of controls, namely WT, *Gad67*^Cre^:*Alk4*^+/+^, and *Alk4*^fl/fl^ mice. A small reduction in PV^+^ cells was detected in cortical layer IV of the mutants when compared with WT mice, but this difference was not statistically significant when compared with the two other control groups ([Fig. 2, C and D](#fig2){ref-type="fig"}). On the other hand, SST^+^ cell numbers were strongly reduced (between 60 and 70%) in all cortical layers of the mutants compared with all three control lines ([Fig. 2 E](#fig2){ref-type="fig"}). RELN^+^ cells were also reduced ([Fig. 2 F](#fig2){ref-type="fig"}), while no major differences were observed in VIP^+^ cells, except for a small increase in layer V, when compared with WT and *Gad67*^Cre^ but not *Alk4*^fl/fl^ mice ([Fig. 2 G](#fig2){ref-type="fig"}). No differences were observed in the number of SST^+^ neurons in the striatum of P30 mutant mice ([Fig. S3 A](#figS3){ref-type="fig"}).

![**Loss of SST^+^ cortical interneurons after deletion of ALK4 in GABAergic cells of the MGE.** **(A)** Representative confocal images of tdTomato fluorescence in the somatosensory cortex of P30 *Gad67*^Cre^:*Rosa26*^tdTom^:*Alk4*^+/+^ mice (left) and *Gad67*^Cre^:*Rosa26*^tdTom^:*Alk4*^fl/fl^ mice (right). Roman numerals indicate cortical layers as detected by DAPI nuclear counterstaining (not shown here). Scale bars, 100 µm. **(B)** Quantification of tdTomato^+^ cells in the P30 somatosensory cortex of the indicated genotypes. Cell counts were normalized to the area of the section that was imaged and averaged per mouse. Data are presented as mean ± SD. *n* = 5 mice per genotype. \*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001; \*\*\*\*, P ≤ 0.0001 (Student's *t* test). **(C)** Representative confocal images of the somatosensory cortex of P30 control (*Alk4*^fl/fl^, left) and mutant (*Gad67*^Cre^:*Alk4*^fl/fl^, right) mice showing fluorescence immunohistochemical detection of PV, SST, RELN, and VIP expression. Roman numerals indicate cortical layers as detected by DAPI nuclear counterstaining (not shown here). Scale bars, 100 µm. **(D--G)** Quantification of PV^+^ (D), SST^+^ (E), RELN^+^ (F), and VIP^+^ (G) cells in the P30 somatosensory cortex of the indicated genotypes. Cell counts were normalized to the area of the section that was imaged and averaged per mouse. Data are presented as mean ± SD. *n* = 5 mice per genotype. P values determined by ANOVA (Bonferroni post hoc test) are indicated as in B. Statistically significant differences between *Gad67*^Cre^:*Alk4*^fl/fl^ mice and all three control groups are indicated in E--G. In D, statistically significant differences were only observed between *Gad67*^Cre^:*Alk4*^fl/fl^ mice and the WT group.](JCB_201905002_Fig2){#fig2}

![**Assessment of SST^+^ cells in the striatum (A) and comparison of tdTomato expression in *Sst*^IRES^*^−^*^Cre^:*Rosa26*^tdTom^ and *Gad67*^Cre^:*Rosa26*^tdTom^ mice 48hs after BrdU labeling (B and C).** **(A)** Immunohistochemically labeled SST cells were counted in the striatum of P30 WT, *Gad67*^Cre^, *Alk4*^fl/fl^, and *Gad67*^Cre^:*Alk4*^fl/fl^ mice. Statistical analysis of the cell counts using ANOVA showed there was no difference in the number of SST cells between genotypes. 40 µm vibratome sections were collected between Bregma 1.7 - -0.94 and every sixth section was fluorescence immunohistochemically labeled for SST. Cells were counted from pictures that were assembled from individual confocal images using the photomerge function in Adobe Photoshop. **(B and C)** Representative confocal images showing immunohistochemical detection tdTomato expression (red) driven by *Sst*^IRES^*^−^*^Cre^ (B) or *Gad67*^Cre^ (C) 48 h after BrdU labeling (green) in the subpallium (diagram) of E14.5 mouse embryos. Insets show a magnified view of the area outlined by a dashed box. Scale bars, 50 µm (main images), 10 µm (insets).](JCB_201905002_FigS3){#figS3}

With the exception of layers II/III, comparable losses of SST^+^ cells were observed in the P30 cortex of *Nkx2.1*^Cre^:*Alk4*^fl/fl^ mice ([Fig. 3, A and B](#fig3){ref-type="fig"}), which specifically targets proliferating precursors of GABAergic cells residing in the SVZ of the MGE ([@bib61]). As indicated by earlier studies ([@bib61]), *Nkx2.1*^Cre^ recombines in only 60% of SST^+^ cells in layers II--IV of the neocortex, and it is therefore likely that a large part of the SST^+^ interneurons that were lost after *Alk4* deletion using the *Gad67*^Cre^ line were spared in the *Nkx2.1*^Cre^ line. Interestingly, we observed no cell losses in *Sst*^IRES^*^−^*^Cre^:*Alk4*^fl/fl^ mice ([Fig. 3, C and D](#fig3){ref-type="fig"}), which induces recombination at later stages and exclusively in SST-expressing cells. In our hands, only a small proportion of MGE-derived interneurons expressed Cre from the *Sst*^IRES^*^−^*^Cre^ locus 48 h after their generation, while the vast majority expressed Cre in the *Gad67*^Cre^ mouse within this period ([Fig. S3, B and C](#figS3){ref-type="fig"}), in accordance with the later onset of *Sst*^IRES^*^−^*^Cre^ locus activation. Together, these results suggest that ALK4 is required in MGE-derived SST interneuron precursors that have just left the cell cycle but not yet begun expression of SST. Importantly, the loss of tdTomato^+^ cells in *Gad67*^Cre^:*Rosa26*^tdTom^:*Alk4*^fl/fl^ mice suggests a loss of interneurons in the mutant cortex, rather than down-regulation of marker gene expression. The normal numbers of SST^+^ cells in the P30 cortex of *Sst*^IRES^*^−^*^Cre^:*Alk4*^fl/fl^ mice also indicated that ALK4 is dispensable for the maintenance of the SST phenotype.

![**Loss of SST^+^ cortical interneurons after ALK4 deletion with *Nkx2.1*^Cre^ but not *Sst*^IRES^*^−^*^Cre.^** **(A)** Representative confocal images of fluorescence immunohistochemical detection of SST^+^ cells in the somatosensory cortex of P30 control *Alk4*^fl/fl^ (left) and mutant *Nkx2.1*^Cre^:*Alk4*^fl/fl^ (right) mice. Roman numerals indicate cortical layers as detected by DAPI nuclear counterstaining (not shown here). Scale bars, 100 µm. **(B)** Quantification of SST^+^ cells in the P30 somatosensory cortex of the indicated genotypes. Cell counts were normalized to the area of the section that was imaged and averaged per mouse. Data are presented as mean ± SD. *n* = 5 mice per genotype. \*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001 (ANOVA, Bonferroni post hoc test). **(C)** Representative confocal images of fluorescence immunohistochemical detection of SST^+^ cells in the somatosensory cortex of P30 control *Alk4*^fl/fl^ (left) and *Sst*^IRES-Cre^:*Alk4*^fl/fl^ (right) mice. Roman numerals indicate cortical layers as detected by DAPI nuclear counterstaining (not shown here). Scale bar, 100 µm. **(D)** Quantification of SST^+^ cells in somatosensory cortex of *Alk4*^fl/fl^ and *Sst*^IRES-Cre^:*Alk4*^fl/fl^ mice. Data are presented as mean ± SD. *n* = 5 mice per genotype. There were no statistically significant differences (P \> 0.05, Student's *t* test).](JCB_201905002_Fig3){#fig3}

Distinct subpopulations of SST^+^ cortical interneurons in layers IV, V, and VI are affected by ALK4 loss in GABAergic cells of the MGE {#s4}
---------------------------------------------------------------------------------------------------------------------------------------

Previous studies have indicated some overlap between SST and RELN expression in subpopulations of MGE-derived GABAergic interneurons ([@bib47]; [@bib36]). In our hands, approximately two thirds of all SST^+^ interneurons in the somatosensory cortex of the P30 mouse brain coexpressed RELN ([Fig. 4, A--C](#fig4){ref-type="fig"}). This was also the subpopulation mostly affected in *Gad67*^Cre^:*Alk4*^fl/fl^ mice, showing significant losses of double-positive neurons in cortical layers II--VI ([Fig. 4 B](#fig4){ref-type="fig"}). In contrast, SST^+^/RELN^−^ cells were not as severely affected in these mutants, with only a relatively smaller reduction in layer VI ([Fig. 4 C](#fig4){ref-type="fig"}). In addition, all cortical layers showed reduced numbers of RELN^+^ neurons that lacked SST expression ([Fig. 4 D](#fig4){ref-type="fig"}). As these cells are thought to be derived from the CGE ([@bib36]), we performed a similar analysis in *Nkx2.1*^Cre^:*Alk4*^fl/fl^ mice, which, as mentioned above, specifically targets GABAergic precursors derived from the MGE ([Fig. 4, E--G](#fig4){ref-type="fig"}). There were no significant losses of SST ^−^/RELN^+^ cells in the cortex of these mice, except for a small group of cells in layer V ([Fig. 4 G](#fig4){ref-type="fig"}), suggesting noncell-autonomous effects of ALK4 on this subpopulation. The loss of SST^+^ interneurons in *Nkx2.1*^Cre^:*Alk4*^fl/fl^ mice was comparable to that observed in *Gad67*^Cre^:*Alk4*^fl/fl^ mice ([Fig. 4, E and F](#fig4){ref-type="fig"}), in agreement with the MGE origin of these cells.

![**Distinct subpopulations of SST^+^ cortical interneurons are affected by ALK4 loss in GABAergic cells of the MGE.** **(A)** Representative confocal images of fluorescence immunohistochemical detection of SST (green) and RELN (red) in the somatosensory cortex of P30 control *Alk4*^fl/fl^ (top row) and mutant *Gad67*^Cre^:*Alk4*^fl/fl^ (bottom row) mice. Insets show magnified views of the areas outlined by the dashed boxes. Roman numerals indicate cortical layers as detected by DAPI nuclear counterstaining (not shown here). Scale bars, 50 µm (main images), 25 µm (insets). **(B--D)** Quantification of SST/RELN double positive (B), SST^+^ RELN^−^ (C), and SST^−^ RELN^+^ (D) cells in control *Alk4*^fl/fl^ (gray bars) and mutant *Gad67*^Cre^:*Alk4*^fl/fl^ (black bars) mice. Cells were counted in confocal images spanning layers I to VI of the P30 somatosensory cortex. Cell counts were normalized to the area of the section that was imaged and averaged per mouse. Data are presented as mean ± SD. *n* = 5 mice per genotype. \*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001; \*\*\*\*, P ≤ 0.0001 (Student's *t* test). **(E--G)**Similar analysis as B--D performed in *Alk4*^fl/fl^ (gray bars) and mutant *Nkx2.1*^Cre^:*Alk4*^fl/fl^ (black bars) mice. **(H)** Representative confocal images of RNAScope in situ hybridization for *Sst* (green) and *Chrna2* (red) mRNAs in layer V of the somatosensory cortex of P30 control *Gad67*^Cre^:*Alk4*^fl/+^ (top row) and mutant *Gad67*^Cre^:*Alk4*^fl/fl^ (bottom row) mice. Inset show magnified view of the area outlined by the dashed box. DAPI nuclear counterstaining is shown in blue. Arrowheads indicate double positive cells. Scale bars, 50 µm (main images), 25 µm (insets). **(I)** Quantification of double positive cells for *Sst* and *Chrna2* mRNAs in cortical layer V of control *Gad67*^Cre^:*Alk4*^fl/+^ (gray bars) and mutant *Gad67*^Cre^:*Alk4*^fl/fl^ (black bars) mice. Cell counts were normalized to the area of the section that was imaged and averaged per mouse. Data are presented as mean ± SD. *n* = 5 mice per genotype. \*, P ≤ 0.05; \*\*, P ≤ 0.01 (Student's *t* test). **(J and K)** Similar analysis as in H and I on double positive cells for *Sst* and *Chodl* mRNAs. VI, cortical layer VI; WM, white matter; ns, not statistically significant difference (Student's *t* test). **(L and M)** Similar analysis as in H and I on double positive cells for *Sst* and *Hpse* mRNAs. V, cortical layer V. \*, P ≤ 0.05; \*\*, P ≤ 0.01 (Student's *t* test).](JCB_201905002_Fig4){#fig4}

Although highly significant, the loss of SST^+^ cortical interneurons in *Alk4* mutant mice was not complete. This could have been due to a stochastic requirement for ALK4 signaling across different SST^+^ interneuron subtypes, or else reflect the existence of subpopulations of SST^+^ cells with distinct requirements. Recent studies have leveraged single-cell RNA-Seq methods to molecularly define distinct populations of cortical GABAergic interneurons, including several subtypes of SST^+^ cells ([@bib34]; [@bib35]; [@bib53]; [@bib67]). Although much remains to be learned about the functional features of many of those subpopulations, a few of the molecular markers identified do label cortical GABAergic neurons with known functional properties. Expression of *Chrna2* (encoding Cholinergic Receptor Nicotinic Alpha 2 Subunit) labels a subpopulation of classical SST^+^ Martinotti cells in layer V ([@bib53], [@bib52]) that extend axons to projection neurons in layer I ([@bib22]). Chondrolectin (encoded by *Chodl*) has been found to mark a distinct class of deep layer SST^+^ cells ([@bib53], [@bib52]) with long-range projections that cross to the contralateral hemisphere ([@bib51]; [@bib24]; [@bib55]). Finally, *Hpse* mRNA (encoding Heparanase) was also recently found to specifically label a subpopulation of SST^+^ cells in cortical layer IV that targets PV^+^ fast-spiking interneurons in the same layer ([@bib67]). This subpopulation is sometimes referred to as X94 cells, since a large fraction of these cells is labeled in the X94 *Gad67*^eGFP^ mouse transgenic line ([@bib29]). Using RNAscope in situ hybridization, we investigated expression of *Chrna2*, *Chodl*, and *Hpse* mRNAs in the cerebral cortex of P30 *Gad67*^Cre^:*Alk4*^fl/fl^ mutant mice and *Gad67*^Cre^:*Alk4*^fl/+^ heterozygote controls ([Fig. 4, H--M](#fig4){ref-type="fig"}). We found that the SST^+^ subpopulation of Martinotti cells expressing *Chrna2* mRNA was almost entirely ablated in the mutants ([Fig. 4, H and I](#fig4){ref-type="fig"}). On the other hand, long-projecting SST^+^ neurons expressing *Chodl* mRNA were spared ([Fig. 4, J and K](#fig4){ref-type="fig"}). Finally, a significant proportion of SST^+^ cells expressing *Hpse* mRNA, up to 50% in layer IV, was also lost in the *Alk4* homozygote mutants ([Fig. 4, L and M](#fig4){ref-type="fig"}). Together, these results suggest a selective dependence on ALK4 signaling among distinct subtypes of SST^+^ interneurons for their correct development.

Altered inhibitory circuitry in cortical layer IV of mice lacking ALK4 in GABAergic cells of the MGE {#s5}
----------------------------------------------------------------------------------------------------

Electrophysiolgical and morphological characterization of layer IV SST^+^ interneurons has shown that, rather than targeting pyramidal neurons, many of these cells contact layer IV PV^+^ interneurons ([@bib29]; [@bib40]; [@bib62]), thereby gating the inhibitory action of PV^+^ cells on pyramidal neurons. As shown above, a significant fraction of these cells, expressing *Hpse* mRNA, was lost in the *Gad67*^Cre^:*Alk4*^fl/fl^ mutants ([Fig. 4, L and M](#fig4){ref-type="fig"}). Also *Nkx2.1*^Cre^:*Alk4*^fl/fl^ mice lacked a sizable fraction of SST^+^ cells in this layer ([Fig. 4 E](#fig4){ref-type="fig"}). We therefore sought to assess whether inhibition of layer IV PV^+^ cells was affected in these mice. To this end, we performed whole cell patch clamp recordings in layer IV PV^+^ cells of P30 *Nkx2.1*^Cre^:*Rosa26*^tdTom^ mice. Layer IV PV^+^ cells were identified by tdTomato expression, as well as their characteristic soma shape and spiking pattern ([Fig. 5, A and B](#fig5){ref-type="fig"}). We compared recordings made in homozygote *Alk4* mutant mice (*Nkx2.1*^Cre^:*Alk4*^fl/fl^:*Rosa26*^tdTom^) to equivalent measurements obtained in heterozygote control mice (*Nkx2.1*^Cre^:*Alk4*^fl/+^:*Rosa26*^tdTom^). We found that both the amplitude and frequency of inhibitory post-synaptic currents (IPSCs) in layer IV PV^+^ neurons were greatly reduced ([Fig. 5, C and D](#fig5){ref-type="fig"}), suggesting that a large proportion of the inhibitory input to these cells may be provided by SST^+^ layer IV interneurons that depend on ALK4 signaling for their development.

![**Altered inhibitory circuitry in cortical layer IV of mice lacking ALK4 in GABAergic cells of the MGE.** **(A)** Schematic representation of patch-clamp experimental setting. **(B)** Representative traces of layer IV fast-spiking cells in heterozygote control (*Nkx2.1*^Cre^:*Alk4*^fl/+^:*Rosa26*^tdTom^) and homozygote mutant (*Nkx2.1*^Cre^:*Alk4*^fl/fl^:*Rosa26*^tdTom^) mice. Top right panel shows post hoc fluorescence detection of tdTomato (red), PV (green), and neurobiotin (Biot, blue) confirming their colocalization. **(C)** Fast-spiking (FS) cell voltage-clamp traces recorded under glutamatergic blockade in order to isolate IPSCs. **(D)** Cumulative distribution of IPSCs' amplitudes in FS-cells of control (black) and *Alk4* mutant (red) mice (top). \*\*\*, P ≤ 0.001, unpaired Kologorov--Smirnov test for continuous probability distributions. Lower panels show amplitude (left) and frequency (right) of FS-cells IPSCs in control (black) and *Alk4* mutant (red) mice. Error bars show mean ± SEM. *n* = 10; \*, P ≤ 0.05 (two-tailed Student's *t* test).](JCB_201905002_Fig5){#fig5}

Perinatal loss of SATB1^+^ interneuron precursors in *Gad67*^Cre^:*Alk4*^fl/fl^ mutant mice {#s6}
-------------------------------------------------------------------------------------------

Comparison of the phenotypes induced by *Gad67*^Cre^, *Nkx2.1*^Cre^, and *Sst^IRES-^*^Cre^ in the P30 cortex of *Alk4*^fl/fl^ mice indicated that ALK4 is required during embryonic stages for the development of SST^+^ interneuron precursors after these became postmitotic, but before the onset of SST expression ([Figs. 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). On the other hand, reduced counts of tdTomato^+^ cells in the P30 cortex of *Gad67*^Cre^:*Rosa26*^tdTom^:*Alk4*^fl/fl^ mice indicated a loss of interneurons in the mature cortex of the mutants. To determine the timing and possible causes of the loss of SST^+^ interneurons, we assessed earlier stages in the development of these cells in *Gad67*^Cre^:*Alk4*^fl/fl^ mice. At postnatal day (P) 5, the loss of SST^+^ cells in the cortex of these mice was comparable to that observed at P30, both in its extent and overall layer distribution ([Fig. 6, A and B](#fig6){ref-type="fig"}). At this stage, there was a comparable reduction in tdTomato^+^ cells in layers II--IV and V, indicating cell loss, although the difference in the combined counts over the total cortex did not reach statistic significance due to large value dispersion in the *Gad67*^Cre^:*Alk4*^fl/+^ mice used as controls ([Fig. 6 C](#fig6){ref-type="fig"}). We note that there was no loss of tdTomato^+^ cells in layer VI, despite 50% reduction in SST^+^ cells in this layer ([Fig. 6, B and C](#fig6){ref-type="fig"}), suggesting that P5 may be a transition stage, with loss of SST expression without equivalent loss of cells. As SST protein is not readily detectable in the mouse cerebral cortex before P2 ([@bib18]), we assessed expression of SATB1, a transcription factor that has been shown to be essential for the development of the SST phenotype in MGE-derived interneurons ([@bib4]; [@bib9]; [@bib13]), at earlier stages. To distinguish MGE-derived SATB1^+^ interneurons from other SATB1^+^ cells in the cortex, we assessed the abundance of SATB1/tdTomato double-positive cells in *Gad67*^Cre^:*Rosa26*^tdTom^:*Alk4*^fl/fl^ newborn (P0) mice in comparison to heterozygote controls (*Gad67*^Cre^:*Rosa26*^tdTom^:*Alk4*^fl/+^). We observed a significant decrease in the number of these cells in the mutants ([Fig. 6, D and E](#fig6){ref-type="fig"}), the magnitude of which was generally consistent with the loss of SST^+^ interneurons observed at later stages. However, there was no loss of tdTomato^+^ cells at P0 when comparing homozygote *Alk4*^fl/fl^ mutants to heterozygote *Alk4*^fl/+^ controls ([Fig. 6 F](#fig6){ref-type="fig"}). The small increases observed in the marginal zone and layer VI, the two main pathways of tangential migration of cortical GABAergic cells, may have been due to a transient delay in the radial invasion of these cells in the mutants. These data suggest that cell loss begins after birth, in early postnatal stages of *Alk4* mutants. At embryonic stages, SATB1 expression has been detected in postmitotic interneuron precursors from E13.5 onward ([@bib4]; [@bib34]). We examined the number of SATB1^+^ cells in the pallium and subpallium of E14.5 embryos, but found no differences between *Alk4* mutants and controls ([Fig. 6, G--I](#fig6){ref-type="fig"}). In agreement with this, *Satb1* mRNA and protein levels were unchanged in the subpallium of E12.5 and E14.5 *Gad67*^Cre^:*Alk4*^fl/fl^ mutant embryos compared with controls ([Fig. S4, A--C](#figS4){ref-type="fig"}). Finally, we also assessed cell proliferation in the MGE of E12.5 *Gad67*^Cre^:*Alk4*^fl/fl^ and *Nkx2.1*^Cre^:*Alk4*^fl/fl^ embryos, but did not detect any differences when compared with their respective controls ([Fig. S4, D--G](#figS4){ref-type="fig"}), indicating that loss of ALK4 has no impact on cell proliferation in the MGE. In summary, although ALK4 signaling is required during embryonic stages for the correct development of MGE-derived SATB1^+^ precursors of interneurons, cells loss does not begin until the first postnatal week of cortical development in the *Alk4* mutants.

![**Perinatal loss of SATB1^+^ SST interneuron precursors in *Gad67*^Cre^:*Alk4*^fl/fl^ mutant mice.** **(A)** Representative confocal images of fluorescence immunohistochemical detection of SST (green) and tdTomato fluorescence (red) in the somatosensory cortex of P5 control (*Gad67*^Cre^:*Alk4*^fl/+^, top row) and mutant (*Gad67*^Cre^:*Alk4*^fl/fl^, bottom row) mice. Roman numerals indicate cortical layers as detected by DAPI nuclear counterstaining (not shown here). Scale bar, 100 µm. **(B and C)**Quantification of SST^+^ (B) and tdTomato^+^ (C) cells in control (*Gad67*^Cre^:*Alk4*^fl/+^, striped bars) and mutant (*Gad67*^Cre^:*Alk4*^fl/fl^, solid bars) mice. Cells were counted in confocal images spanning layers I to VI of the P5 somatosensory cortex. Cell counts were normalized to the area of the section that was imaged and averaged per mouse. Data are presented as mean ± SD. *n* = 6 (control) or 5 (mutant) mice. \*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001 (Student's *t* test). **(D)** Representative confocal images of fluorescence immunohistochemical detection of SATB1 (green) and tdTomato (red) in the cortex of P0 control (*Gad67*^Cre^:*Rosa26*^tdTom^:*Alk4*^fl/+^, top row) and mutant (*Gad67*^Cre^:*Rosa26*^tdTom^:*Alk4*^fl/fl^, bottom row) mice. Roman numerals indicate cortical layers as detected by DAPI nuclear counterstaining, and layer VI was further verified by TBR1 immunolabeling (not shown here). Insets show magnified views of the areas outlined by the dashed boxes. Scale bars, 50 µm (main images), 10 µm (insets). **(E and F)** Quantification of SATB1^+^/tdTomato^+^ double-positive (E) and tdTomato^+^ single-positive (F) cells in control (*Gad67*^Cre^:*Rosa26*^tdTom^:*Alk4*^fl/+^, striped bars) and mutant (*Gad67*^Cre^:*Rosa26*^tdTom^:*Alk4*^fl/fl^, solid bars) newborn mice. Cells were counted in confocal images from the marginal zone (here labeled MZ) to layer VI of the P0 cortex. Cell counts were normalized to the area of the section that was imaged and averaged per mouse. Data are presented as mean ± SD. *n* = 6 mice per genotype. \*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001 (Student's *t* test). **(G)** Diagram of a coronal section through the E14.5 mouse brain left hemisphere with boxes indicating the approximate location of images shown in H. **(H)** Representative confocal images of fluorescence immunohistochemical detection of SATB1 (green) in the pallium and subpallium of control (*Gad67*^Cre^:*Alk4*^fl/+^, left) and mutant (*Gad67*^Cre^:*Alk4*^fl/fl^, right) mice as indicated in G. Scale bars, 50 µm. **(I)** Quantification of SATB1^+^ cells in control (*Gad67*^Cre^:*Alk4*^fl/+^, striped bars) and mutant (*Gad67*^Cre^:*Alk4*^fl/fl^, solid bars) E14.5 mouse embryos. Cells were counted in confocal images of the pallium and subpallium in one hemisphere and averaged per mouse. Data are presented as mean ± SD. *n* = 6 mice per genotype. There were no statistically significant differences (P \> 0.05, Student's *t* test).](JCB_201905002_Fig6){#fig6}

![**Unaltered *Satb1* mRNA and protein levels and cell proliferation in the MGE of *Alk4* mutant embryos.** **(A)** Quantification of Satb1 mRNA expression by qRT-PCR analysis of E12.5 and E14.5 basal forebrain samples of *Alk4*^fl/fl^ control (gray bars) and *Gad67*^Cre^:*Alk4*^fl/fl^ (black bars) embryos. Results are presented as mean ± SD. *n* = 8 (E12.5 *Alk4*^fl/fl^), 6 (E12.5 *Gad67*^Cre^:*Alk4*^fl/fl^), 8 (E14.5 *Alk4*^fl/fl^), 7 (E14.5 *Gad67*^Cre^:*Alk4*^fl/fl^). There were no significant differences (ANOVA, Bonferroni post-hoc test). **(B)** Representative Western blot of whole cell lysates from E12.5 and E14.5 basal forebrain samples from *Alk4*^fl/fl^ control and *Gad67*^Cre^:*Alk4*^fl/fl^ embryos probed with antibodies to SATB1 (top) and αTubulin (bottom) as control. **(C)** Quantification of SATB1 protein expression relative to αTubulin in E12.5 and E14.5 basal forebrain samples from *Alk4*^fl/fl^ control (gray bars) and *Gad67*^Cre^:*Alk4*^fl/fl^ (black bars) embryos. Results are presented as mean ± SD. *n* = 4 embryos per genotype. There were no significant differences (ANOVA, Bonferroni post hoc test). **(D)** Representative confocal images of immunohistochemical detection of BrdU (magenta) in MGE sections from E12.5 control (*Gad67*^Cre^:*Alk4*^fl/+^) and mutant (*Gad67*^Cre^:*Alk4*^fl/fl^) embryos. Embryos were harvested 30 min after the BrdU pulse. Scale bars, 50 µm. **(E)** Quantification of BrdU^+^ cells in the MGE of E12.5 control (*Gad67*^Cre^:*Alk4*^fl/+^) and mutant (*Gad67*^Cre^:*Alk4*^fl/fl^) embryos as indicated. Cell counts were normalized to the area of the section that was imaged and averaged per mouse. Results are presented as mean ± SD. *n* = 4 (*Gad67*^Cre^:*Alk4*^fl/+^) and 7 (*Gad67*^Cre^:*Alk4*^fl/fl^). There were no significant differences (Student's *t* test). **(F and G)** Similar analysis to E and F on *Nkx2.1*^Cre^:*Alk4*^fl/fl^ mutant embryos and controls. *n* = 4 (*Nkx2.1*^Cre^:*Alk4*^fl/+^) and 5 (*Nkx2.1*^Cre^:*Alk4*^fl/fl^). There were no significant differences (Student's *t* test). A.U., arbitrary units.](JCB_201905002_FigS4){#figS4}

Activin A regulates SATB1 function through ALK4 in MGE cells {#s7}
------------------------------------------------------------

Our analysis of SATB1^+^ cells and *Satb1* mRNA and protein levels indicated that the initial expression of this transcription factor is correctly established in the subpallium of *Gad67*^Cre^:*Alk4*^fl/fl^ mutant embryos. We therefore considered the possibility that ALK4 signaling may regulate SATB1 function or its subcellular localization in MGE-derived SST interneuron precursors. To assess these possibilities, we established primary cultures of dissociated MGE cells and investigated whether stimulation with activin A, one of the major ligands of ALK4, affected the nuclear localization of SATB1. Activin A induced a significant increase in SATB1 in the nuclei of E12.5 ([Fig. 7, A and B](#fig7){ref-type="fig"}) and E14.5 ([Fig. S5, A and B](#figS5){ref-type="fig"}) MGE cells, with a peak at 30 min. Similar results were obtained using biochemical methods in Jurkat cells ([Fig. S5 C](#figS5){ref-type="fig"}), a T cell--derived cell line that is often used in functional studies of SATB1. In MGE cells, the effects of activin A on the nuclear localization of SATB1 were suppressed by the ALK4 inhibitor SB43152 ([Fig. 7, C and D](#fig7){ref-type="fig"}), and activin A had no effect on MGE cells derived from *Gad67*^Cre^:*Alk4*^fl/fl^ mutant embryos ([Fig. 7, E and F](#fig7){ref-type="fig"}). Together, these results suggest that ALK4 signaling may regulate SATB1 function in MGE cells, at least in part, by controlling its nuclear localization.

![**Activin A induces SATB1 nuclear localization in MGE cells.** **(A)** Representative confocal images of fluorescence immunohistochemical detection of SATB1 (green) in cultured MGE cells from WT E12.5 embryos, counterstained for the neuronal marker Tuj1 (red) and DAPI (blue), after treatment with activin A for the indicated periods of time. Insets show magnified views of areas outlined by dashed boxes. Scale bars, 50 µm (main images), 25 µm (insets). **(B)** Quantification of MGE cells displaying nuclear SATB1^+^ after activin A treatment. Results are expressed as percentage of the total cells (mean ± SEM). *n* = 6; \*\*, P \< 0.01 compared with vehicle (one-way ANOVA, P = 0.0083, followed by Bonferroni). **(C and D)** Similar analysis as in A and B in response to 60 min treatment with activin A or the ALK4 inhibitor compound SB431542 as indicated. *n* = 4; \*, P \< 0.05; \*\*\*, P \< 0.001 compared with vehicle (one-way ANOVA, P \< 0.001, followed by Bonferroni multiple comparisons test). **(E and F)** Similar analysis as in A and B in response to 60 min treatment with activin A on cultured MGE cells derived from control (*Gad67*^Cre^:*Alk4*^+/+^, left) or mutant (*Gad67*^Cre^:*Alk4*^fl/fl^, right) E12.5 embryos as indicated. *n* = 3; \*, P \< 0.05 compared with vehicle (two-way ANOVA, P = 0.0305, followed by Bonferroni multiple comparisons test).](JCB_201905002_Fig7){#fig7}

![**Activin A induces SATB1 nuclear localization and interaction with Smad 2 in MGE and Jurkat cells.** **(A)** Representative confocal images of fluorescence immunohistochemical detection of SATB1 (green) in cultured MGE cells from WT E14.5 embryos, counterstained for the neuronal marker Tuj1 (red) and DAPI (blue), after treatment with activin A for the indicated periods of time. Insets show magnified views of areas outlined by dashed boxes. Scale bars, 50 µm (main images), 25 µm (insets). **(B)** Quantification of E14.5 MGE cells displaying nuclear SATB1^+^ after activin A treatment. Results are expressed as percentage of the total cells (mean ± SEM). *n* = 5; \*, P \< 0.05; \*\*, P \< 0.01 compared with vehicle (one-way ANOVA, P = 0.00957, followed by HSD Tukey). **(C)** Representative Western blots of SATB1 in cytosolic and nuclear fractions prepared from Jurkat cells treated with activin A for the indicated periods of time. Below, quantification of SATB1 in nuclear fractions relative to cytosolic fractions. Results are expressed as mean ± SEM. *n* = 4; \*, P \< 0.05 compared with vehicle (one-way ANOVA \[P = 0.0235\] followed by HSD Tukey). **(D)** Representative Western blots of Smad2 and SATB1 in SATB1 immunoprecipitates prepared from Jurkat cells treated with activin A with or without SB431542 (SB) for the indicated periods of time. Below, quantification of Smad2 coimmunoprecipitated by SATB1 antibodies normalized to SATB1. Results are expressed as mean ± SEM. *n* = 3; \*, P \< 0.05; \*\*, P \> 0.01 compared with vehicle (one-way ANOVA \[P = 0.0042\] followed by HSD Tukey).](JCB_201905002_FigS5){#figS5}

Activation of type I receptors of the TGFβ superfamily, including ALK4, induces the phosphorylation and nuclear translocation of Smad proteins ([@bib49]; [@bib5]; [@bib33]). We tested the hypothesis that Smad proteins activated by ALK4 may promote the nuclear translocation of SATB1 by direct interaction. To this end, we used the proximity ligation assay (PLA) in cell cultures derived from E12.5 MGE and assessed the interaction between SATB1 and Smad2 under control conditions and in response to activin A. We could detect basal levels of SATB1/Smad2 interaction in control cultures, which were significantly increased following 30 min treatment with activin A ([Fig. 8, A and B](#fig8){ref-type="fig"}). Interestingly, a great proportion of the PLA signal in the cultures treated with activin A was found in the cell nucleus ([Fig. 8 A](#fig8){ref-type="fig"}, inset). The SB43152 inhibitor blocked the effect of activin A on SATB1/Smad2 interaction ([Fig. 8, C and D](#fig8){ref-type="fig"}), and activin A had no effect on MGE cells derived from *Gad67*^Cre^:*Alk4*^fl/fl^ mutant embryos ([Fig. 8, E and F](#fig8){ref-type="fig"}). Similar results were obtained using biochemical methods in Jurkat cells ([Fig. S5 D](#figS5){ref-type="fig"}).

![**Activin A induces interaction of SATB1 with Smad2 in MGE cells.** **(A)** Representative confocal images of fluorescence immunohistochemical detection of SATB1/Smad2 interaction (PLA, yellow) in cultured MGE cells from WT E12.5 embryos, counterstained for the neuronal marker Tuj1 (green) and DAPI (blue), after treatment with activin A for the indicated periods of time. Insets show magnified views of areas outlined by dashed boxes. Scale bars, 20 µm (main images), 10 µm (insets). **(B)** Quantification of SATB1/Smad2 interaction by PLA in MGE cells after activin A treatment. Results are expressed as percentage of PLA^+^ cells relative to the total number of cells (mean ± SEM). *n* = 3; \*, P \< 0.05 compared with vehicle (one-way ANOVA, P = 0.01376; followed by Bonferroni multiple comparisons test). **(C and D)** Similar analysis as in A and B in response to 30 min treatment with activin A or the ALK4 inhibitor compound SB431542 as indicated. *n* = 4; \*\*\*, P \< 0.001 compared with vehicle (one-way ANOVA, P \< 0.001, followed by Bonferroni multiple comparisons test). **(E and F)**Similar analysis as in A and B in response to 30 min treatment with activin A on cultured MGE cells derived from control (*Gad67*^Cre^:*Alk4*^+/+^, left) or mutant (*Gad67*^Cre^:*Alk4*^fl/fl^, right) E12.5 embryos as indicated. *n* = 4; \*\*, P \< 0.01 compared with vehicle (two-way ANOVA, P = 0.0055, followed by Bonferroni multiple comparisons test).](JCB_201905002_Fig8){#fig8}

Finally, we investigated whether the effects of activin A on SATB1 may have a functional significance for SATB1's role as transcriptional regulator in MGE cells. SATB1 has emerged as a key factor integrating higher-order chromatin architecture with gene regulation. It has also been shown to regulate genes by directly binding to upstream regulatory elements, thereby recruiting chromatin modifiers, corepressors, and coactivators directly to gene promoters ([@bib7]; [@bib1]; [@bib21]). Several reports have shown that SATB1 shows preference for interaction with DNA sequences containing ATC/G triplets ([@bib12] [@bib14] [@bib25]). An enhancer region located 600 bp upstream of the transcription start site of the *Sst* gene has been implicated in its regulation by homeobox transcription factors Pdx1 and Pax6 ([@bib2]). Several ATC/G triplets are located in this enhancer, which could potentially serve as binding sites for SATB1. To test this notion, we performed chromatin immunoprecipitation assays using antibodies specific for SATB1 as well as control antibodies against cAMP response element-binding protein (CREB), which interacts with a different site in the *Sst* gene promoter ([@bib37]), and control mouse IgG. We performed PCR amplifications targeting a proximal (R1) and a distal (R2) region, each of ∼100 bp, within the *Sst* gene enhancer. Both regions could be recovered in SATB1 immunoprecipitates derived from cultures of E12.5 MGE cells ([Fig. 9, A and B](#fig9){ref-type="fig"}). No PCR products could be recovered using antibodies against CREB or control mouse IgG (data not shown). Interestingly, treatment of MGE cells with activin A significantly reduced SATB1 interaction with R1 but increased interaction with R2 ([Fig. 9, A and B](#fig9){ref-type="fig"}), suggesting that activin A signaling through ALK4 can induce relocalization of SATB1 within upstream enhancer sequences in the *Sst* gene of MGE cells.

![**Activin A induces relocation of SATB1 within enhancer regions of the *Sst* gene promoter in MGE cells.** **(A)** Quantification of SATB1 interaction with promoter-proximal R1 enhancer sequence of the *Sst* gene assessed by chromatin immunoprecipitation in MGE cells. Results are presented as mean ± SEM. *n* = 4. \*, P \< 0.05 compared with vehicle (Student's *t* test, P = 0.035). **(B)** Similar analysis to A on promoter-distal R2 enhancer sequence of the *Sst* gene. *n* = 4. \*, P \< 0.05 compared with vehicle (Student's *t* test, P = 0.0431). IP, immunoprecipitation; Vh., vehicle.](JCB_201905002_Fig9){#fig9}

Discussion {#s8}
==========

Cortical GABAergic interneurons are generated during mouse embryonic development from proliferating progenitors in transient neurogenic zones of the developing basal forebrain. In the MGE, combinations of transcription factors have been suggested to prepattern different areas of the VZ and SVZ destined to generate different classes of interneurons ([@bib17]). For example, Nkx2.1 expression marks proliferating progenitors common to both PV^+^ and SST^+^ interneurons ([@bib61]). As they move apically to the mantle zone, these cells leave the cell cycle and begin expression of GABAergic markers, such as GAD67. Topographical transcriptome analysis of this region revealed a progression in the expression of subsets of genes implicated in interneuron differentiation, neuronal migration, and neuronal projection, as the cells move ventro-laterally ([@bib64]). From the MGE, GABAergic cells migrate tangentially to colonize the developing cortex and hippocampus ([@bib11]; [@bib30]; [@bib58]). Throughout these processes, extracellular factors have so far been mainly implicated in the guidance of migrating GABAergic cells from the subpallium to the pallium and in the developing neocortex (e.g., [@bib16]; [@bib48]; [@bib28]). On the other hand, whether extracellular signals interact with intrinsic transcriptional programs to promote the specification of interneuron subtypes in the subpallium or beyond remains less well understood. The studies presented here implicate activin signaling through the type I TGFβ superfamily receptor ALK4 in the development of SST^+^ interneurons through regulation of the intracellular localization and activity of SATB1, a key transcriptional regulator of the differentiation and maturation of these cells. ALK4 was expressed in Lhx6^+^ cells of the MGE during the peak of SST^+^ interneuron generation along with several of its ligands. The effects of the ALK4 inhibitor SB43152 on SATB1 nuclear localization on cultured neurons derived from the MGE also suggest endogenous production of ligands by these cells. ALK4 could therefore be part of a quorum-sensing mechanism ensuring that appropriate numbers of SST interneuron precursors are generated during embryonic development.

The loss of tdTomato^+^ cells in the cortex of *Gad67*^Cre^:*Rosa26*^tdTom^:*Alk4*^fl/fl^ mice at P30 and P5 indicates a loss of interneurons, rather than mere down-regulation of marker gene expression. At P30, this loss was quantitatively comparable to the combined loss observed in nonoverlapping subpopulations of PV^+^, SST^+^, and SST^−^/RELN^+^ interneurons, indicating that these are all the major cell types affected by the loss of ALK4 in GABAergic cells of the developing basal forebrain. At P5, however, the loss of tdTomato^+^ cells was lower than that expected from the SST^+^ counts, particularly in layer VI, suggesting that this stage may be close to the onset of cell elimination in the mutants. Although the *Sst* gene initiates transcription during the later stages of embryonic development ([@bib4]), SST protein is not detected until the first postnatal days in the mouse brain ([@bib18]). To visualize SST interneuron precursors, we used SATB1 as a prospective marker of these cells. We note that, although SATB1 is also expressed by PV^+^ cells, the latter population was not as significantly affected by the loss of ALK4 as the SST^+^ population when analyzed in the adult brain (compare [Fig. 2, D and E](#fig2){ref-type="fig"}). Therefore, we believe that the vast majority of changes detected perinatally in SATB1^+^/tdTomato^+^ cells should represent changes of the SST interneurons. While the loss of SATB1^+^ cells at birth was quantitatively consistent with the extent of SST^+^ neuron loss observed later in the cortex, we did not detect a comparable loss of tdTomato^+^ cells at this stage, indicating that phenotypic defects precede cell elimination in the *Alk4* mutant cortex. At E14.5, no loss of SATB1^+^ cells could be detected in the pallium or subpallium of the mutants. In addition, ALK4 was dispensable for the proliferation of VZ and SVZ progenitors of these cells, and it was also dispensable for the maintenance of the SST phenotype, as *Sst^IRES-^*^Cre^:*Alk4*^fl/fl^ mice showed no loss of SST^+^ interneurons. Based on these observations, we conclude that ALK4 is required for the correct development of SST interneuron precursors during a relatively narrow time window of embryonic development, after these cells become postmitotic and GABAergic, but before they activate the *Sst* locus itself a few days later. Lack of ALK4 signaling during this critical period resulted in impaired differentiation at later stages, as shown by an inability to maintain normal SATB1 expression at birth, and eventually cell elimination during the first postnatal week. Many factors are known to act transiently during early stages to influence phenotypes that manifest later in development. We note that the timing of cortical SATB1^+^/SST^+^ cell elimination in the *Alk4* mutants approximately coincided with the period of intrinsic elimination of cortical GABAergic cells identified by recent studies, which was reported to occur between P3 and P13, with a marked peak at P7 ([@bib50]). It is possible that this intrinsic cell death may serve to eliminate GABAergic cells that failed to differentiate properly, as in the case of our *Alk4* mutants.

Unlike several other interneuron classes, SST^+^ cells in cortical layer IV, also referred to as X94 cells, target PV^+^ fast-spiking interneurons in the same layer ([@bib62]). The morphology of these cells also differs from other SST^+^ interneurons, as they are often described as bitufted or multipolar cells with local axonal projections ([@bib29]; [@bib63]). *Alk4* deletion driven by either *Gad67*^Cre^ or *Nkx2.1*^Cre^ resulted in the loss of about two thirds of SST^+^ cells in layer IV, and approximately half of the cells expressing *Hpse* mRNA, now considered a specific marker of X94 cells ([@bib67]). The significant loss of X94 cells in the *Alk4* mutants correlated with the reduction in both the amplitude and frequency of IPSCs in PV^+^ interneurons in the same layer. Although it has been shown that fast spiking PV^+^ interneurons can inhibit other PV^+^ cells in this layer, the moderate decrease in PV^+^ neurons that we detected in *Alk4* mutants (statistically significant only with respect to WT layer IV, but not in comparison to all other controls) would seem insufficient to account for the substantial effect observed on inhibition, which was \>75%. Based on these results, we conclude that X94 cells are a subpopulation of SST/HPSE double positive interneurons that depend on ALK4 for their correct development. Because of the early requirement of ALK4 for the development of these cells, our results provide functional evidence for the prespecification of the X94 phenotype during embryonic stages. A Martinotti subtype of layer V SST^+^ interneurons that project to layer I was completely ablated in the *Alk4* mutants, indicating their absolute dependence on ALK4 signaling during early embryonic stages. On the other hand, no loss of *Chodl* mRNA^+^ cells could be detected, indicating that not all subtypes of cortical SST^+^ neurons depend on ALK4 for their correct development. Intriguingly, these cells are in fact long-projecting GABAergic neurons, not properly interneurons, a fact that may be related to their ALK4 independence. Together, these results suggest that dependence on ALK4 is not stochastic among developing precursors of SST interneurons, but rather that some subtypes have a strict dependence on ALK4 for their correct specification, while others are totally independent.

SATB1 has been shown to be essential for the specification of the SST interneuron phenotype ([@bib4]; [@bib9]; [@bib13]; [@bib44]). SATB1 can affect gene expression at multiple levels. It can tether different genomic loci to help coordinate their expression, recruit chromatin-remodeling enzymes to regulate chromatin structure, and interact directly with gene promoter and enhancer regions to engage coactivators or corepressors ([@bib1]; [@bib7]; [@bib46]). Our finding of an interaction between Smad proteins and SATB1 brings a new perspective on the functions of this genome organizer and transcriptional regulator, linking its activity to information carried by extracellular signals. SATB1 bears an atypical nuclear localization signal ([@bib43]), and the regulation of SATB1 subcellular localization is not well understood. A proteomics study found altered levels of SATB1 in the nuclear fraction of human CD4^+^ T cells upon stimulation with IL-4 ([@bib38]), suggesting that the nuclear localization of SATB1 is indeed susceptible to regulation by extracellular stimuli, although the mechanisms involved were not elucidated. We found that activin signaling could increase the nuclear localization of SATB1 in MGE-derived neurons, and PLA studies indicated that SATB1 could be found in complex with Smad2 in the nucleus of these cells, suggesting that activated Smad proteins may bring along SATB1 as they shuttle to the cell nucleus. Using chromatin immunoprecipitation, we found that activin signaling altered the interaction of SATB1 within the enhancer region of the *Sst* gene in MGE cells, decreasing its binding to a distal region while increasing it to a more proximal region. This result suggests that, through SATB1, activin signaling contributes to reorganize the *Sst* locus in preparation for initiation of gene transcription. We note, however, that *Sst* mRNA levels were not increased in cultured MGE cells stimulated with activin A, suggesting that activin signaling is not itself sufficient to regulate *Sst* gene transcription.

In summary, the results of the present study reveal a previously unknown level of regulation in the specification of cortical interneuron subtypes mediated by an extracellular signal during early embryonic development. It is likely that many other transcriptional programs affecting cortical interneuron diversification also interact with extracellular signals in the environment of the ganglionic eminences and along the migratory routes of interneuron precursors to coordinate GABAergic interneuron development in the mammalian brain.

Materials and methods {#s9}
=====================

Mice {#s10}
----

Mice were housed in a 12-h light--dark cycle and fed a standard chow diet. The *Alk4*^fx^ knock-in allele was generated by introducing LoxP sites in the IVth and VIth introns of the *Acvr1b* gene, encoding ALK4 ([Fig. S1 A](#figS1){ref-type="fig"}). Targeting vectors were generated using BAC clones from the C57BL/6J RPCIB-731 BAC library and transfected into TaconicArtemis C57BL/6N Tac ES cell line. Gene-targeted mice were generated at TaconicArtemis by standard methods. Both female and male mice were used in the study. The day of vaginal plug was considered embryonic day 0.5 (E0.5). All animal procedures are in accordance with Karolinska Institute's ethical guidelines and were approved by Stockholms Norra Djurförsöksetiska Nämnd.

Antibodies {#s11}
----------

The primary antibodies used for immunohistochemistry were as follows: mouse anti-PV (1:1,000, 235, Swant), rabbit anti-SST (1:2,000, T-4103, Peninsula), mouse anti-RELN (1:1,000, MAB5364, Millipore), rabbit anti-VIP (1:500, 20077, Immunostar), goat anti-SATB1 (1:100, sc5889, Santa Cruz), anti-RFP (1:500, 600--401-379, Rockland), and rat anti-BrdU (1:500, OBT0030G, Accurate Chemicals). The secondary antibodies used for immunohistochemistry, all raised in donkey and used at 1:2,000 dilution, were as follows: anti-mouse Alexa Fluor 488 (A21202, Invitrogen), anti-mouse Alexa Fluor 555 (A31571, Invitrogen), anti-rabbit Alexa Fluor 555 (A31572, Invitrogen), anti-goat Alexa Fluor 488 (A11055, Invitrogen), anti-rat Alexa Fluor 647 (712--606-153, Jackson Immunoresearch), and anti-rat Alexa Fluor 488 (A21208, Invitrogen).

Tissue preparation, fluorescence immunohistochemistry, and in situ hybridization {#s12}
--------------------------------------------------------------------------------

Male and female P30 mice were deeply anaesthetized and transcardially perfused with PBS and 4% PFA in PBS, and brains were dissected and postfixed overnight at 4°C. 40-µm free-floating coronal sections were cut at the vibratome (VTS 1200, Leica) and subjected to fluorescence immunohistochemistry: blocking, permeabilization, and antibody incubation were performed in 5% normal donkey serum (NDS; Jackson Immunoresearch), 0.2% Tx-100 in PBS. Primary antibodies were incubated overnight at 4°C, secondary antibodies for 2 h at RT. Nuclei were visualized with DAPI. All washes were performed with PBS, pH 7.4. Sections were mounted on object slides, air-dried, and coverslipped using DAKO fluorescence mounting medium (Dako North America). P5 mice were anaesthetized and transcardially perfused with PBS, and their brains were dissected out and fixed overnight in 4% PFA. P0 mice and embryos were quickly decapitated and the heads rinsed in PBS and immersed in 4% PFA (6 h to overnight). Brains were cryoprotected in 30% sucrose and embedded in OCT cryomount (Histolab Products AB) for cryostat sectioning. Coronal sections (16 µm, series of 10 for P5 and P0 mice; 12 µm, series of 8 for embryos) were thaw-mounted onto Superfrost^+^ slides (Menzel Gläser), air-dried, stored at −80°C, and subjected to immunohistochemistry as described below. To detect BrdU, sections were incubated in 1M HCl for 45 min at 37°C followed by 15 min at RT in 10 mM Tris-HCl, pH 8.0, and washes in PBS before the general protocol outlined above. Detection of SATB1 required heat-mediated antigen retrieval in 10 mM citric acid buffer, pH 6.0, before the general immunohistochemical procedure. For RNAscope, embryos were rapidly decapitated, and the heads were fresh frozen in OCT and stored at −80°C. Adult mice were anaesthetized and decapitated, and their brains were dissected out for freezing in OCT and storage at −80°C. Coronal cryostat sections (10 µm thick) were thaw mounted onto Superfrost^+^ slides and stored at −80°C until further processing. In situ hybridization was performed using RNAscope technology (Advanced Cell Diagnostics Biotechne), following the manufacturer's protocol. The following probes were used: Alk4 (Mm-Acvr1b, 429271; Mm-Lhx6-C3, 422791-C3).

Image acquisition and analysis {#s13}
------------------------------

Images were acquired using a LSM700 confocal microscope (Zeiss). To analyze the expression of interneuron markers at P30, a 15.86-µm confocal stack was imaged in the somatosensory cortex from every sixth section between Bregma 1.94 mm and −2.18 mm. At P5 and P0, corresponding regions were imaged. Embryonic sections containing both MGE and lateral ganglionic eminence (LGE) were imaged using the tile scan function. To analyze recombination efficiency, images from three nonadjacent sections from the somatosensory cortex were acquired. Cells were counted using the Cell Counter plugin in ImageJ (National Institutes of Health ImageJ 1.51), and counts are reported as mean ± SD. Statistical data analysis was performed using GraphPad Prism 5.

Quantitative real-time PCR (qRT-PCR) {#s14}
------------------------------------

E12.5 and E14.5 control and mutant embryos were decapitated and their brains dissected in ice-cold sterile PBS supplemented with 1% glucose. MGE and LGE were frozen on dry ice in Eppendorf tubes and stored at −80°C. RNA extraction and cDNA synthesis were performed in parallel for all samples. Total RNA was extracted using the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol. Subsequent to a DNaseI digest (Invitrogen Thermo Fisher Scientific) cDNA was synthesized from 250 µg of total RNA primed with random hexamers using SuperScript II (Invitrogen). qRT-PCR analysis was performed using SYBR green PCR Master Mix (Applied Biosystems) according to the manufacturer's protocol on a StepOnePlus continuous fluorescence detector (Applied Biosystems) under standard cycling conditions. The oligonucleotides used were as follows: Gdf1 reverse (Rv): 5′-AGG​TCA​AAG​ACG​ACT​GTC​CA-3′; InhbA forward (Fw): 5′-ATC​ATC​ACC​TTT​GCC​GAG​TC-3′; InhbA Rv: 5′-ACA​GGT​CAC​TGC​CTT​CCT​TG-3′; InhbB Fw: 5′-CTT​CGT​CTC​TAA​TGA​AGG​CAA​CC-3′; InhbB Rv: 5′-CTC​CAC​CAC​ATT​CCA​CCT​GTC-3′; Satb1 Fw: 5′-ACA​GTA​AGG​AAT​GCT​CTG​AAG​G-3′, Satb1 Rv: 5′-CTG​TTC​ACA​ATG​GAG​GAG​ATC​A-3′; 18S Fw: 5′-CAC​ACG​CTG​AGC​CAG​TCA​GT-3′; 18S Rv: 5′-AGG​TTT​GTG​ATG​CCC​TTA​GAT​GTC-3′. Formation of specific amplicons was verified by melt curve analysis; gene expression was quantified relative to 18S ribosomal RNA.

Acute slice electrophysiology {#s15}
-----------------------------

Postnatal day 15 to 19 *Nkx2.1*^Cre^:*Rosa26*^tdTom^:*Alk4*^f^*^l/+^* and *Nkx2.1*^Cre^:*Rosa26*^tdTom^:*Alk4*^fl/fl^ pups were anesthetized and brains were collected in ice-cold solution of the following composition (in mM): 62.5 NaCl, 100 sucrose, 2.5 KCl, 25 NaHCO~3~, 1.25 NaH~2~PO~4~, 7 MgSO~4~, 1 CaCl~2~, and 10 glucose. Subsequently, brains were sectioned to 300-µm slices, which were then left to recover for 1 h at RT in oxygenated aCSF (in mM): 125 NaCl, 2.5 KCl, 25 NaHCO~3~, 1.25 NaH~2~PO~4~, 2 MgSO~4~, 2 CaCl~2~, and 10 glucose. During whole-cell patch-clamp recordings, slices were perfused with oxygenated aCSF at 24 ± 2°C. Patch electrodes were made from borosilicate glass (resistance 4--8 MΩ; Hilgenberg, GmbH) and filled with a solution containing (in mM): 65 K-gluconate, 65 KCl, 10 Hepes, 10 Na-Phosphocreatine, 0.5 EGTA, 4 MgATP, and 0.3 Na~2~GTP. We targeted layer 4 cells in the somatosensory cortex, either tdTomato-positive (to enrich for PV-positive fast-spiking neurons) or -negative (for excitatory neurons). Intrinsic properties of cells were recorded in current clamp and analyzed as previously described ([@bib41]). In our conditions, the Cl^−^ reverse potential determines an outward current of this ion when GABA receptors are open, shown in the recordings as excitatory currents. To measure IPSCs, neurons were recorded in voltage-clamp mode held at −70 mV in aCSF containing glutamatergic blockers CNQX/MK-801 (10 µM/5 µM, Sigma-Aldrich) for at least 10 min. Currents were recorded with an Axopatch 200B amplifier (Molecular Devices), sampled at 10 kHz, processed with Digidata 1322A (Molecular Devices), and analyzed on Clampex. Traces were low-pass filtered (1 KHz), only events with amplitude larger than −10 pA were included in the analysis, and frequency was calculated as total number of events per time. Data are mean ± SEM. P values are from Student's two-tailed *t* tests.

Cell culture {#s16}
------------

For primary culture of MGE cells, brains from E12.5 or E14.5 mouse embryos were collected and placed in ice-cold PBS supplemented with 1% glucose. The MGE was dissected out and digested with EDTA-Trypsin buffer (GIBCO BRL Thermo Fisher Scientific) for 15 min. Trypsin was inactivated with 25% FBS (Gibco), and cells were dissociated through a glass pipette in the presence of 25 ng DNase (Roche). Cells were collected by centrifugation during 5 min at 800 *g* and resuspended in Neurobasal Medium (Gibco) supplemented with B27 (Gibco), 2 mM glutamine (Gibco), and 20 µg/ml penicilin/stretptomicyn. MGE cells were plated at a density of 50,000 cells per coverslip in a 24-well plate or, alternatively, at 150,000 cells per well in 12-well plates, both coated with 100 µg/ml poly-D-lysine and 2 µg/ml of Laminin (Cultrex, RnD). Cells were maintained for 2 d at 37°C in 95% O~2~/5% CO~2~ atmosphere before the start of the experiments.

Jurkat cells were growth in RPMI-1640 medium containing 2 mM glutamine (Gibco), 20 μg/ml penicillin/streptomycin (Gibco), and 10% FBS (Gibco) at 37°C in 95% O~2~/5% CO~2~ atmosphere.

Satb1 nuclear translocation and proximity ligation assays in MGE cells {#s17}
----------------------------------------------------------------------

After 2 d in culture, MGE cell monolayers were treated with activin A at 100 ng/ml (RnD) for the indicated periods of time. In some experiments, the ALK4 inhibitor SB41542 (Sigma-Aldrich) was added at 10 µM 60 min before the addition of activin A, or on its own. At the end of the treatment, cells were washed twice with PBS and fixed for 15 min in 4% PFA/4% sucrose, permeabilized, and blocked in 10% normal donkey serum and 0.3% Triton X-100 in PBS. Cells were then incubated overnight at 4°C with anti-SATB1 (Santa Cruz, sc5989, 1:400), and anti-TuJ1 (βIII Tubulin, Sigma-Aldrich, MAB1637, 1:2,000) in PBS supplemented with 5% NDS and 0.05% Triton X-100. After washing with PBS, the cultures were incubated with the appropriate secondary antibody. Secondary antibodies were Alexa Fluor--conjugated anti-immunoglobulin from Life Technologies and Invitrogen, used at 1:1,000 (donkey anti-rabbit IgG Alexa Fluor 555, A31572; donkey anti-goat IgG Alexa Fluor 488, A11055; donkey anti-mouse IgG Alexa Fluor 488, A21202; donkey anti-mouse IgG Alexa Fluor 555, A31570; donkey anti-mouse IgG Alexa Fluor 647, A31571; donkey anti-goat IgG Alexa Fluor 555, A21432). For PLA, cells were fixed as above and incubated overnight at 4°C with anti-SATB1 (Santa Cruz, sc5989, 1:200), anti-Smad2 (Cell Signaling, 5339, 1:100), and anti-Tuj1 (Sigma-Aldrich, MAB1637, 1:2,000) antibodies in PBS supplemented with 3% BSA. The Duolink In situ Proximity Ligation kit (Sigma-Aldrich) was then used as per manufacturer's instructions with fluorophore-conjugated secondary antibody to recognize Tuj1 (donkey anti-mouse IgG Alexa Fluor 488, A21202, 1:1,000) included during the amplification step. Cells were imaged with an Zeiss LSM700 confocal laser microscope. Image analysis was performed using Natonal Institutes of Health ImageJ 1.51 and GraphPad Prism 5.

Western blotting, immunoprecipitation, and nuclear fractionation {#s18}
----------------------------------------------------------------

Protein samples of Jurkat cells were prepared for SDS-PAGE in SDS sample buffer (Life Technologies). Protein samples of MGE tissue were lysed in RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0) containing protease inhibitor (Roche) using a 25-G syringe. Total protein concentration was measured using a Dc-Protein Assay (Bio-Rad). 25 µg of protein were loaded per sample. Protein samples were boiled at 95°C for 10 min before electrophoresis 12% polyacrylamide gels. Proteins were transferred to polyvinylidene fluoride membranes (Amersham). Membranes were blocked with 5% nonfat milk and incubated with primary antibodies. The primary antibodies used for Western blotting and immunoprecipitation were as follows: goat anti-SATB1 (Santa Cruz, 5889, 1:600); rabbit anti-Smad2 (Cell Signaling, 5339, 1:1,500); and mouse anti-αTubulin (Sigma-Aldrich, T6199, 1:2,000). HRP-conjugated secondary antibodies for Western blotting were from DAKO (Agilent). Immunoblots were developed using Clarity Western ECL (Bio-Rad) or SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific). Images were acquired through a LAS 4000-ImageQuant System (GE Healthcare); quantification of band intensities was done with ImageQuant software (GE Healthcare). For immunoprecipitation, cells were lysed with RIPA buffer containing protease inhibitor (Roche). Total protein was collected and incubated with anti-Satb1 antibody (Santa Cruz, 5889, 1:50) overnight at 4°C and then incubated with SepharoseProtein-G beads (GE Healthcare). Samples were then prepared for immunoblotting as described above. For nuclear/cytoplasmic fractionation, nuclear and cytosolic fractions were collected using the NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific) according to the manufacturer's protocol.

Chromatin immunoprecipitation {#s19}
-----------------------------

MGE cells were treated with activin A (100 ng/ml) for 60 min, collected by trypsinization, and washed twice in ice-cold PBS. Cells of 3 wells from 12-well plates were pooled together (∼450,000 cells in total). DNA--protein complexes were cross-linked by incubating the cells with 37% formaldehyde (final concentration 1%) for 8 min. DNA was then purified and immunoprecipitated using a HighCell ChIP Kit (Diagenode) according to the manufacturer's protocol. DNA was sheared by sonication using a Sonicator (Diagenode): 10 cycles (30 s on, 30 s off) at high power setting. DNA was immunoprecipitated using an anti-SATB1 antibody (Santa Cruz, X-5889, 6.3 µg/sample), or anti-CREB (Abcam, 31387, 6.3 µg/sample) or mouse-IgG (provided with the kit). Immunoprecipitates were amplified and analyzed by real-time quantitative PCR (qPCR) using SybrGreen reagents (Applied Biosystems). The following qPCR primers were used: SST-promoter-R1: Fw: 5′-CCT​GTA​GGG​ATC​ATC​TCG​TCC-3′, Rv: 5′-GGC​CAG​AGT​TCT​GAC​TGC​TTT3′; SST-promoter-R2: Fw 5′-ACT​CTG​GCC​TGA​ACA​GTA​AAC​AT3′, Rv: 5′-TCA​GCT​CTG​CCT​GAT​CTC​CTA3′; and IL2a-promoter: Fw 5′-GGG​GGT​GGG​GAT​ACA​AAG​TAA3′, Rv: 5′-TCT​TGC​TCT​TGT​CCA​CCA​CAA​TA3′.

Statistical analysis {#s20}
--------------------

Statistics analyses were performed using Prism 5 software (GraphPad, SPSS IBM) and Microsoft Excel (Microsoft). Student's *t* test, one-way ANOVA, or two-way ANOVA was performed to test statistical significance according the requirements of the experiment (e.g., comparisons across one or two variables, respectively). Bonferroni test was used as a further analysis for experiments that required multiple comparisons. Statistical analysis of cumulative curves was done with the unpaired Kologorov--Smirnov test, which tests the similarity of continuous probability distributions, without any assumptions on data distribution, and is often used to analyze cumulative curves. Differences were considered statistically significant when P \< 0.05. All P values are reported in Table S1.

Online supplemental material {#s21}
----------------------------

[Fig. S1](#figS1){ref-type="fig"} shows the generation of a conditional allele of the mouse Acvr1b gene encoding ALK4 and analysis of Alk4 mRNA expression in the MGE of Alk4 mutant mice. [Fig. S2](#figS2){ref-type="fig"} shows expression of mRNAs encoding ALK4 ligands in the embryonic basal forebrain and assessment of recombination efficiency driven by Gad67Cre in cortical GABAergic interneurons. [Fig. S3](#figS3){ref-type="fig"} shows an assessment of SST^+^ cells in the striatum and comparison of tdTomato expression in SstIRES-Cre:Rosa26tdTom and Gad67Cre:Rosa26tdTom mice 48 h after BrdU labeling. [Fig. S4](#figS4){ref-type="fig"} shows unaltered Satb1 mRNA and protein levels and cell proliferation in the MGE of Alk4 mutant embryos. [Fig. S5](#figS5){ref-type="fig"} shows that activin A induces SATB1 nuclear localization and interaction with Smad 2 in MGE and Jurkat cells.

Supplementary Material
======================
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Click here for additional data file.
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